China Biotech Services Holdings Limited (HKG:8037)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.6200
0.00 (0.00%)
Jul 31, 2026, 2:39 PM HKT

HKG:8037 Balance Sheet

Millions HKD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
12.0818.9172.0992.77150.55
Trading Asset Securities
----1.76
Cash & Short-Term Investments
12.0818.9172.0992.77152.31
Cash Growth
-36.11%-73.76%-22.30%-39.09%-60.52%
Accounts Receivable
5.627.0319.76751.992.13
Other Receivables
7.1614.0925.231.844.24
Receivables
12.7821.1345761.37109.63
Inventory
36.943.979.2718.734.74
Prepaid Expenses
10.751.99-4.751.57
Restricted Cash
0.010.01-02.14
Other Current Assets
7.1217.08134.817.147.38
Total Current Assets
79.6963.1261.17884.76277.77
Property, Plant & Equipment
401.94235.34124.22128.86105.49
Long-Term Investments
30.6643.2356.9299.16122.02
Goodwill
108.84103.89107.18110.08120.55
Other Intangible Assets
31.7734.9457.6467.3180.94
Other Long-Term Assets
49.6849.4655.24180.32-
Total Assets
702.58529.96662.361,470706.78

Liabilities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
33.77.355.79206.4416.15
Accrued Expenses
27.3920.3523.177.1628.19
Short-Term Debt
-138.6930.965.6417.39
Current Portion of Long-Term Debt
240.2-53.88-38.65
Current Portion of Leases
6.965.719.8310.987.58
Current Income Taxes Payable
0.40.123.7324285.2
Other Current Liabilities
37.1120.3932.186.4434.25
Total Current Liabilities
345.76192.61159.47548.66227.4
Long-Term Debt
142.0841.64-55.8-
Long-Term Leases
5.661.795.739.373.56
Long-Term Deferred Tax Liabilities
4.055.046.447.899.94
Other Long-Term Liabilities
49.2846.48-22.25-
Total Liabilities
546.83287.57171.64643.97240.89

Shareholders' Equity

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
97.5797.5796.3296.3296.32
Additional Paid-In Capital
494.18494.18490.69490.69490.69
Retained Earnings
-603.25-534.47-310.8-209.91-475.13
Comprehensive Income & Other
202.9207.65186.54225.57283.52
Total Common Equity
191.41264.94462.75602.68395.4
Minority Interest
-35.67-22.5527.97223.8570.5
Shareholders' Equity
155.75242.39490.73826.52465.9
Total Liabilities & Equity
702.58529.96662.361,470706.78

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
394.9187.83100.481.7867.17
Net Cash (Debt)
-382.82-168.92-28.3110.9985.14
Net Cash Growth
----87.10%-69.53%
Net Cash Per Share
-0.39-0.17-0.030.010.09
Filing Date Shares Outstanding
975.73975.73963.23963.23963.23
Total Common Shares Outstanding
975.73975.73963.23963.23963.23
Working Capital
-266.07-129.52101.7336.0950.38
Book Value Per Share
0.200.270.480.630.41
Tangible Book Value
50.81126.1297.93425.28193.91
Tangible Book Value Per Share
0.050.130.310.440.20
Land
15.2115.2115.2115.2115.21
Machinery
30.3124.66177.31183.07155.86
Construction In Progress
419.84255.1863.645.88-
Leasehold Improvements
9.971115.316.7712.16